{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:27:01Z","timestamp":1791584821916,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7242195"],"award-info":[{"award-number":["7242195"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","award":["7212152"],"award-info":[{"award-number":["7212152"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277006"],"award-info":[{"award-number":["22277006"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273772"],"award-info":[{"award-number":["82273772"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejmech.2024.116993","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T15:43:30Z","timestamp":1729525410000},"page":"116993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Design, synthesis, and pharmacological characterization of sulfonylurea-based NLRP3 inhibitors: Towards an effective therapeutic strategy for Alzheimer's disease"],"prefix":"10.1016","volume":"280","author":[{"given":"Weiping","family":"Lyu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongfei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruohan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangren","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8993-4015","authenticated-orcid":false,"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejmech.2024.116993_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","article-title":"Alzheimer's disease","volume":"25","author":"Lane","year":"2018","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116993_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1385\/JMN:20:2:203","article-title":"The relationship between amyloid and tau","volume":"20","author":"Hardy","year":"2003","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116993_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3389\/fnins.2016.00205","article-title":"Multi-target directed donepezil-like ligands for Alzheimer's disease","volume":"10","author":"Unzeta","year":"2016","journal-title":"Front. Neurosci."},{"issue":"10","key":"10.1016\/j.ejmech.2024.116993_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2174\/138955708785740652","article-title":"From dual binding site acetylcholinesterase inhibitors to multi-target-directed ligands (MTDLs): a step forward in the treatment of alzheimers disease","volume":"8","author":"Bolognesi Laura","year":"2008","journal-title":"Mini-Rev. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116993_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(99)01637-3","article-title":"Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution","volume":"463","author":"Greenblatt","year":"1999","journal-title":"FEBS Lett."},{"issue":"9","key":"10.1016\/j.ejmech.2024.116993_bib6","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/0968-0896(96)00137-X","article-title":"The rationale for E2020 as a potent acetylcholinesterase inhibitor","volume":"4","author":"Kawakami","year":"1996","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116993_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept\u00ae): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.ejmech.2024.116993_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"36","key":"10.1016\/j.ejmech.2024.116993_bib9","doi-asserted-by":"crossref","first-page":"E3825","DOI":"10.1073\/pnas.1410315111","article-title":"Design of donecopride, a dual serotonin subtype 4 receptor agonist\/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment","volume":"111","author":"Lecoutey","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2024.116993_bib10","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fncel.2014.00112","article-title":"Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches","volume":"8","author":"Morales","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"6","key":"10.1016\/j.ejmech.2024.116993_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11064-005-6962-9","article-title":"Basal forebrain cholinergic dysfunction in alzheimer's disease \u2013 interrelationship with \u03b2-amyloid, inflammation and neurotrophin signaling","volume":"30","author":"Schliebs","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejmech.2024.116993_bib12","article-title":"The role of NLRP3 inflammasome in alzheimer's disease and potential therapeutic targets","volume":"13","author":"Liang","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116993_bib13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12979-023-00395-z","article-title":"The role of NLRP3 inflammasome in aging and age-related diseases","volume":"21","author":"Liang","year":"2024","journal-title":"Immun. Ageing"},{"key":"10.1016\/j.ejmech.2024.116993_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1125982","article-title":"Microglia: a pharmacological target for the treatment of age-related cognitive decline and Alzheimer's disease","volume":"14","author":"McKee","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116993_bib15","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/cns.14082","article-title":"Aurantiamide suppresses the activation of NLRP3 inflammasome to improve the cognitive function and central inflammation in mice with Alzheimer's disease","volume":"29","author":"Shen","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejmech.2024.116993_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fnint.2020.00037","article-title":"Key mechanisms and potential targets of the NLRP3 inflammasome in neurodegenerative diseases","volume":"14","author":"Guan","year":"2020","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.ejmech.2024.116993_bib17","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3233\/JAD-210400","article-title":"A novel inhibitor targeting NLRP3 inflammasome reduces neuropathology and improves cognitive function in alzheimer's disease transgenic mice","volume":"82","author":"Kuwar","year":"2021","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejmech.2024.116993_bib18","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bbi.2016.12.014","article-title":"Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-\u03b2 and cognitive function in APP\/PS1 mice","volume":"61","author":"Dempsey","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejmech.2024.116993_bib19","doi-asserted-by":"crossref","first-page":"579","DOI":"10.3233\/JAD-210660","article-title":"The NLRP3 inflammasome in the pathogenesis and treatment of alzheimer's disease","volume":"84","author":"Golzari-Sorkheh","year":"2021","journal-title":"J. Alzheim. Dis."},{"key":"10.1016\/j.ejmech.2024.116993_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.3233\/JAD-230567","article-title":"NLRP3 inflammasome: an emerging therapeutic target for alzheimer's disease","volume":"96","author":"Tao","year":"2023","journal-title":"J. Alzheim. Dis."},{"issue":"11","key":"10.1016\/j.ejmech.2024.116993_bib21","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1007\/s11064-020-03121-z","article-title":"Mechanisms of NLRP3 inflammasome activation: its role in the treatment of alzheimer's disease","volume":"45","author":"Zhang","year":"2020","journal-title":"Neurochem. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116993_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","article-title":"Tau and neuroinflammation in Alzheimer's disease: interplay mechanisms and clinical translation","volume":"20","author":"Chen","year":"2023","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejmech.2024.116993_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.122813","article-title":"NLRP3 Inflammasome: a central player in renal pathologies and nephropathy","volume":"351","author":"Henedak","year":"2024","journal-title":"Life Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116993_bib24","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4062\/biomolther.2023.099","article-title":"NLRP3 inflammasome as therapeutic targets in inflammatory diseases","volume":"31","author":"Prakash","year":"2023","journal-title":"Biomolecules & Therapeutics"},{"key":"10.1016\/j.ejmech.2024.116993_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100889","article-title":"The NLRP3 inflammasome: mechanism of action, role in disease and therapies","volume":"76","author":"Wang","year":"2020","journal-title":"Mol. Aspect. Med."},{"issue":"S13","key":"10.1016\/j.ejmech.2024.116993_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/alz.075563","article-title":"Age-equivalent induced neurons from patients reveal neuronal fate loss and metabolic transformation underlying neurodegeneration in sporadic Alzheimer's disease","volume":"19","author":"Mertens","year":"2023","journal-title":"Alzheimer's Dementia"},{"issue":"12","key":"10.1016\/j.ejmech.2024.116993_bib27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.stem.2022.11.010","article-title":"Increased post-mitotic senescence in aged human neurons is a pathological feature of Alzheimer's disease","volume":"29","author":"Herdy","year":"2022","journal-title":"Cell Stem Cell"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424008754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T06:25:34Z","timestamp":1732170334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424008754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":27,"alternative-id":["S0223523424008754"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116993","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design, synthesis, and pharmacological characterization of sulfonylurea-based NLRP3 inhibitors: Towards an effective therapeutic strategy for Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116993"}}